Literature DB >> 23643980

Effects of UCMS-induced depression on nociceptive behaviors induced by electrical stimulation of the dura mater.

Mingjie Zhang1, Wei Dai, Jingyao Liang, Xiaoyan Chen, Yueqing Hu, Bingqian Chu, Meiyan Pan, Zhao Dong, Shengyuan Yu.   

Abstract

The comorbidity between migraine and depression not only provides a major treatment challenge, but also represents a heavy burden on society. However, the relationship between depression and migraine and their molecular biological mechanisms remain unclear. This study investigated the effects of depression elicited by unpredictable chronic mild stress (UCMS) on trigeminovascular nociception in conscious rats and detected a concentration of calcitonin gene-related peptide (CGRP) and substance P (SP) in the external jugular vein. We divided the rats into four groups: control-stimulated (C/S), control-nonstimulated (C/NS), UCMS-stimulated (U/S), and UCMS-nonstimulated (U/NS). We stimulated the dura mater adjacent to the superior sagittal sinus of rats in the C/S and U/S groups and observed their nociceptive behaviors. We found significant differences between the UCMS and control groups in weight, sucrose preference, and locomotor behavior. Nociceptive behaviors (number of head flicks and head-turning time) were significantly increased in the U/S compared with the C/S group, and head-turning time correlated with depressive-like behaviors. The plasma level of SP was increased significantly in the U/NS compared with the C/NS group. However, no significant differences involving the other groups were observed. UCMS-induced depression can exacerbate trigeminovascular nociception, making rats more sensitive to pain.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CGRP; Depression; Migraine; Nociceptive behavior; OB; SP; SSRIs; UCMS; calcitonin gene-related peptide; olfactory bulbectomy; selective serotonin reuptake inhibitors; substance P; unpredictable chronic mild stress

Mesh:

Substances:

Year:  2013        PMID: 23643980     DOI: 10.1016/j.neulet.2013.04.038

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 2.  Pain and depression comorbidity: a preclinical perspective.

Authors:  Jun-Xu Li
Journal:  Behav Brain Res       Date:  2014-05-02       Impact factor: 3.332

3.  Effect of electroacupuncture pretreatment at GB20 on behaviour and the descending pain modulatory system in a rat model of migraine.

Authors:  Pei Pei; Lu Liu; Luopeng Zhao; Yingxue Cui; Zhengyang Qu; Linpeng Wang
Journal:  Acupunct Med       Date:  2015-10-05       Impact factor: 2.267

4.  Electroacupuncture Pretreatment at GB20 Exerts Antinociceptive Effects via Peripheral and Central Serotonin Mechanism in Conscious Migraine Rats.

Authors:  Lu Liu; Pei Pei; Luo-Peng Zhao; Zheng-Yang Qu; Yu-Pu Zhu; Lin-Peng Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-24       Impact factor: 2.629

5.  Depression and anxiety behaviour in a rat model of chronic migraine.

Authors:  Mingjie Zhang; Yufei Liu; Mangsuo Zhao; Wenjing Tang; Xiaolin Wang; Zhao Dong; Shengyuan Yu
Journal:  J Headache Pain       Date:  2017-02-21       Impact factor: 7.277

6.  Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.

Authors:  Qing Zhang; Xun Han; Hangfei Wu; Mingjie Zhang; Guanqun Hu; Zhao Dong; Shengyuan Yu
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

Review 7.  High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity.

Authors:  Marie Fitzgibbon; David P Finn; Michelle Roche
Journal:  Int J Neuropsychopharmacol       Date:  2015-09-05       Impact factor: 5.176

Review 8.  Chronic migraine: A process of dysmodulation and sensitization.

Authors:  Min Su; Shengyuan Yu
Journal:  Mol Pain       Date:  2018-04-12       Impact factor: 3.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.